openPR Logo
Press release

2023 Dravet Syndrome Market Players Adopting to Ensure Sustainability | Biocodex, Biscayne Neurotherapeutics, Cyberonics, Inc., Epygenix Therapeutics, Inc., GW Pharmaceuticals, plc

11-28-2018 09:20 AM CET | Health & Medicine

Press release from: Market Research Future

2023 Dravet Syndrome Market Players Adopting to Ensure

Market Research Future recently presented Global Dravet Syndrome Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2023.

Dravet Syndrome Market - Highlights

Dravet Syndrome is a severe form of the epileptic disorder that initiates in the first year of an otherwise healthy infant. Around 85% of children with Dravet syndrome develop myoclonic seizures between 1-5 years.

Many factors such as the development of new drugs and therapies, rising R&D expenditure, unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are propelling the growth of the global Dravet syndrome market.

GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5474

However, side effects of drugs and other therapeutic agents, lack of awareness in the developing countries, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the Dravet syndrome market is expected to grow at a CAGR of 8.5% during the forecast period, 2017-2023.

Dravet Syndrome Market - Regional Analysis

The Americas dominate the Dravet syndrome market owing to the presence of a large number of leading market players, rising development of new drugs, and high healthcare expenditure.

Various U.S.-based pharmaceutical companies such as Zogenix, Inc., Insys Therapeutics, Inc., and OPKO Health, Inc. are continuously putting efforts to come up with novel drugs to control Dravet syndrome and related complications.

Europe holds the second position in the Dravet syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.

Asia Pacific is the fastest growing Dravet syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries.

According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Dravet Syndrome Market - Segmentation

The global Dravet syndrome market is segmented on the basis of the type of seizures, diagnosis, treatment & management, and end-user.

On the basis of the type of seizures, the market is classified as myoclonic seizures, atonic seizures, partial seizures, absence seizures, tonic clonic seizures, photosensitive seizures, and others.

On the basis of the diagnosis, the market is classified as magnetic resonance imaging (MRI), electroencephalography (EEG), SCN1A testing, and others.

On the basis of the treatment & management, the market is classified as seizure medications, ketogenic diet, vagus nerve stimulation (VNS), and others. The seizure medications segment is further classified into clobazam, stiripentol, sodium valproate, and others.

On the basis of the end-user, the market is segmented into pharmaceutical companies, hospitals, diagnostic laboratories, academic and research institutes, and others.

Dravet Syndrome Market - Key Players

Some of key the players in the global Dravet syndrome market are Biocodex, Biscayne Neurotherapeutics, Cyberonics, Inc., Epygenix Therapeutics, Inc., GW Pharmaceuticals, plc, INSYS THERAPEUTICS, INC., OPKO Health Inc., Ovid Therapeutics, PTC Therapeutics, Sage Therapeutics, Takeda Pharmaceutical Company Limited, Thermo Fisher Life Technologies, Xenon Pharmaceuticals, Zogenix, Inc, and others.

OBTAIN COMPLETE 110 PAGES PREMIUM RESEARCH REPORT DETAILS ENABLED WITH RESPECTIVE 40+ TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/laser-resurfacing-market-5474

Major Points form TOC for Dravet Syndrome Market Research Report – Forecast to 2023

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global DRAVET SYNDROME Market, By Type

Chapter 7. Global DRAVET SYNDROME Market, By Treatment

Chapter 8 Global DRAVET SYNDROME Market, By End User

Chapter 9. Global DRAVET SYNDROME Market, By Region

Chapter 10 Company Landscape

Chapter 11 Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13 Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2023 Dravet Syndrome Market Players Adopting to Ensure Sustainability | Biocodex, Biscayne Neurotherapeutics, Cyberonics, Inc., Epygenix Therapeutics, Inc., GW Pharmaceuticals, plc here

News-ID: 1404186 • Views: 588

More Releases from Market Research Future

Dermal Fillers Market Business Insights & Deep Analysis to 2025 by World’s Top …
Market Scope The global dermal filler market can reach a valuation of USD 6,899.16 million by 2025. It is predicted to expand at a CAGR of 13.2% over the forecast period. Dermal fillers or wrinkle fillers are solutions injected into the skin. Its effects can last from six months to two years. Efforts are being made to prolong its effects and revolutionize anti-aging. The global dermal filler market report by Market Research
Field Programmable Gate Array Market 2021 Size, Share, Industry Analysis, Emergi …
Field Programmable Gate Array Market by technology (EEPROM, Antifuse, SRAM, Flash, and others (EPROM and PROM), by Application (data processing, consumer electronics, industrial, military & aerospace, automotive, telecom, and others), and by Type (high-end, mid-end, and low-end FPGA) - Global Opportunity Analysis and Industry Forecast, 2017-2023 According to a recent report published by Allied Market Research, titled, Field Programmable Gate Array Market by Technology, Application, and Type: Global Opportunity Analysis and
Semiconductor IC Tester Market Growth Factor, Demand, Size, Share, Trends, Growt …
The Semiconductor IC Tester Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the Semiconductor IC Tester market growth. Semiconductor IC Tester is
Tilt Sensor Market Share, COVID-19 Pandemic Impact, Comprehensive Analysis, Oppo …
Global Tilt Sensor Market Highlights: The global Tilt Sensor Market is growing rapidly over 7.42% of CAGR and is expected to reach at USD 257.64 million by the end of forecast period. The global tilt sensor market has been witnessing a steady growth over the last few years on account of rapid growth of automobile and transportation market, high implementation of sensors in the constructions machines and rising demand for tilt

All 5 Releases


More Releases for Dravet

Dravet Syndrome Treatment Market Global Industry Demand, Recent Trends, Size and …
Dravet syndrome is a distressing infantile-onset epilepsy, which is sometimes accompanied by severe intellectual disabilities, autistic traits, hyperactive behavior, and ataxia. Discovery of SCN1A mutation in 2001 as a primary cause of this syndrome has accelerated the knowledge of the pathophysiological processes behind Dravet syndrome. View Report : https://www.transparencymarketresearch.com/dravet-syndrome-treatment-market.html SCN1A is responsible for encoding the ?-subunit of the voltage-gated sodium channel NaV1.1. Recent studies, using genetically modified mouse models, have indicated
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Dravet Syndrome Treatment Market Trends in 2019- What Industry Insiders Tell Us …
MarketResearchReports.Biz announces addition of new report "Dravet Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026" to its database. Dravet syndrome is a distressing infantile-onset epilepsy, which is sometimes accompanied by severe intellectual disabilities, autistic traits, hyperactive behavior, and ataxia. Discovery of SCN1A mutation in 2001 as a primary cause of this syndrome has accelerated the knowledge of the pathophysiological processes behind Dravet syndrome.
Dravet Syndrome Treatment Market - Substantial Rise in Industrial Sectors to Off …
The newly released research at Up Market Research titled “2019 - 2025 Global Dravet Syndrome Treatment Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years. This report presents a comprehensive overview, market shares, and growth opportunities of Dravet Syndrome Treatment Market by product type, application, key manufacturers and key regions. Request Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/77681 Dravet Syndrome Treatment
Global Dravet Syndrome Treatment Market Status, Share, Significant Trends, Drive …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Dravet Syndrome Treatment Market Insights, Forecast to 2025” which provides an outlook for current market value as well as the expected growth of Dravet Syndrome Treatment Market during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import
Dravet Syndrome Treatment Market - Global Industry Insights, 2026
Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic seizures, absence seizures, atypical absence seizures, atonic seizures, focal aware or impaired awareness seizures (previously